4222 articles
Ultra-widefield retinal imaging tech company Optos announced the dual milestone of installing 25,000 devices worldwide and the collection of 2,500 peer-reviewed studies spanning 235 disease states.
Biopharmaceutical company Telios Pharma has revealed positive topline results from its phase 2 study of TL-925, a first-in-class topical Bruton’s tyrosine kinase (BTK) inhibitor for individuals with dry eye disease (DED).
The newest addition to Eyespace’s portfolio of award-winning house brands, Arhlo, drew crowds at Mido with a collection of 36 gender-neutral styles championing individuality while remaining affordable
Always evolving, Maison Lafont is honouring French savoir-faire by joining forces with Maison Pierre Frey to create a dynamic new collaboration. Inspired by the richness of Maison Pierre Frey, Thomas Lafont has incorporated its fabrics into the company’s new eyewear collection, creating six new sung
US researchers have found patients prescribed acetylcholinesterase inhibitors (AChEIs) to treat Alzheimer’s disease have a lower risk of developing age-related macular degeneration (AMD), compared wit
An Australian study of video-gamers found 46.1% of its 955 participants complained of eye fatigue, the second most commonly reported physical ailment after back or neck pain (52.1%). Researchers
A blend of chokeberry, honeysuckle berry and bilberry extract improved near visual acuity and conjunctival hydration in presbyopic subjects, a Polish study found. The randomised, double-blind,
The World Council of Optometry (WCO) has launched a new resource aimed at harmonising the optometry profession and enhancing optometric education globally. The Competency Framework for Optomet
A new clinical study showed patients wearing Neurolenses had improved scores on a validated headache questionnaire. Using the Headache Impact Test (HIT) questionnaire, Neurolenses’ contoured-pr
Nearly at capacity, O-Show 2024 is gearing up for a busy event from 17-18 May at Sydney’s Hordern Pavilion.
Simple adjustments to how eyecare practices communicate with patients may attract a significantly higher number of contact lens (CL) wearers, according to new data from the Contact Lens Institute (CLI
Promising interim results from the phase 2 trial of Beacon Therapeutics' gene therapy to treat RP present a challenger to Luxturna.
